Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M618Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-22.0EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)28.3Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.0PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M4,150,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IHE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Element, MartynDirector 2016-08-08Buy10,000$0.15100346.67view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell200$12.11145.21view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell1,800$12.11145.21view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell2,000$12.111144.18view
Ghuldu, RishiSenior Officer 2016-08-08Sell149$23.45542.52view
Louis, PeterSenior Officer 2016-08-08Sell5,000$87.8671.49view
Omni-Lite Industries Canada InIssuer 2016-08-08Buy5,000$1.78762.94view
Omni-Lite Industries Canada InIssuer 2016-08-08Buy4,700$1.659031.52view
Kovacevic, John GianniDirector, Senior Officer 2016-08-08Buy200,000$0.08188237.5view
Espaillat Lamarche, Julio ErneSenior Officer 2016-08-08Sell190,000$0.625011.67view

Quarterly/Annual Reports about IHE:

    News about IHE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Pfizer’s Products with Decreasing Revenues Aug 11 2016
    Pharma ETFs Soaring on Solid Q2 Earnings Aug 03 2016
    Trending on ETFdb.com: Emerging Markets and Dividend Kings Garner Interest Jun 02 2016
    Government Study: Cellphone Radiation Linked To Cancer May 27 2016
    Mudslinging Over Valeant Pharmaceuticals May 07 2016
    Pharma ETFs Outlook -- Drug Pricing Issues Remain in Focus May 04 2016
    Finding Pharmaceuticals ETFs With Rebound Potential May 04 2016
    The Last Week of April Wasn’t Good for Biotechnology Stocks May 02 2016
    Fertilizer Impact: Natural Gas Prices Rise Yet Again for Week Ending April 22 Apr 28 2016
    A Segment-by-Segment Breakdown of JNJ’s 1Q16 Earnings Apr 25 2016
    5 Best Performing Bull Run Equity ETFs Mar 09 2016
    Drug Patent Expirations: $190 Billion Is Up for Grabs Mar 03 2016
    Other Industries That Depend on Specialty Chemicals—and Why Mar 02 2016
    Look Beyond Pharma to Opportunities in Generics! Mar 01 2016
    What Does 2016 Hold in Store for Pharma ETFs Jan 04 2016
    How Will Johnson & Johnson’s Pharmaceutical Segment Do in 4Q15? Dec 31 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)